Original ResearchPublished 9 October 2026Functional ovarian reserve in women with Hodgkin and non-Hodgkin lymphomasFrancesca Filippi · Nicole Serra · Sabrina Comana · Giorgia Di Stefano · Marco Reschini · Paola Vigano’ · Edgardo SomiglianaFrontiers in Oncologydoi 10.3389/fonc.2026.1965843
Original ResearchPublished 30 September 2026Comparative outcomes of conventional follitropin delta 15 µg/day versus follitropin alfa 225 IU/day for ovarian stimulation: results from an exploratory post hoc analysis of Spanish participants from the ADAPT-1 randomized controlled trialMarta García Sánchez · Andrea Bernabeu · Ana Hernández Cesteros · Laura Blasco Gastón · Sofia Ortega Ricondo · Gemma Castillón · Marcos Ferrando Serrano · Signe Møgelmose · Enrica Gravotta · Rita LoboFrontiers in Reproductive Healthdoi 10.3389/frph.2026.1927550
Original ResearchPublished 16 September 2026Corifollitropin alfa versus daily recombinant FSH for ovarian stimulation in women of advanced maternal age: a cost-minimization analysis in an out-of-pocket settingG. N. Cecchino · B. R. Carvalho · Y. Ramires · R. L. P. Bueno · L. A. Lucio · V. P. SantanaFrontiers in Reproductive Healthdoi 10.3389/frph.2026.1939114
